Kun-Huei Yeh

11PUBLICATIONS
42CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 15, 2026
FAP-1 loss impairs megakaryocyte demarcation membrane system and platelet function with myelofibrosis-like features.

|Jun 08, 2026
Post-adjuvant chemotherapy in ctDNA-positive patients with resected colorectal cancer: a randomized phase 3 trial.

|Apr 18, 2025
Metastatic Colon Cancer Recurring After Cetuximab Plus Doublet Chemotherapy Harboring Acquired KRAS G12C Mutant that Responded to Sotorasib Plus Cetuximab.

Ching-Cheng Chang, Yi-Hsin Liang, Been-Ren Lin

|Apr 11, 2025
Overall Survival Analysis of the Phase III CodeBreaK 300 Study of Sotorasib Plus Panitumumab Versus Investigator's Choice in Chemorefractory KRAS G12C Colorectal Cancer.

Filippo Pietrantonio, Lisa Salvatore, Taito Esaki

|Sep 16, 2024
ctDNA-based molecular residual disease and survival in resectable colorectal cancer.

Yoshiaki Nakamura, Jun Watanabe, Naoya Akazawa

|Nov 02, 2022
Novel prognostic implications of complement activation in the tumour microenvironment for de novo metastatic BRAF V600E mutant colorectal cancer.

Kuo-Hsing Chen, Chia-Lang Hsu, Yu-Li Su

Pageof 2

Frequent Collaborators

2 joint publications

Liang-In Lin

2 joint publications

Ann-Lii Cheng

2 joint publications

Hideaki Bando

2 joint publications

Yoshiaki Nakamura